CONMED Corporation Announces Fourth Quarter and Fiscal Year 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street wavers as Federal Reserve holds key rate steady, pending more data
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise on Yemen fighting, Saudi refinery attack
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
CONMED (CNMD) PT Raised to $71 at Needham & Company
February 1, 2018 6:22 AM ESTNeedham & Company raised its price target on CONMED (NASDAQ: CNMD) to $71.00 (from $58.00) while maintaining a Buy rating.
Analyst Mike Matson commented, "CNMD's 4Q17 revenue and EPS beat consensus and management guided to above-consensus 2018 revenue and EPS. Its revenue growth improved to... More



